mortality/aging
• double mutants develop breathing difficulties after 7 - 8 months of age
|
• frequent embryonic lethality; however, a significant number of double mutants survive
|
neoplasm
• a large spectrum of multifocal lesions are seen in the lung including; small patches of bronchiolo-alveolar hyperplasias to large bronchiolo-alveolar adenomas that compress adjacent lung structures and appear to derive from type II pneumocytes
|
• large bronchiolo-alveolar adenocarcinomas that compress adjacent lung structures and appear to derive from type II pneumocytes
|
• histiocytic sarcoma and other sarcomas seen in 2 out of 20 and 3 out of 20 double mutants, respectively
|
• anal papillomas seen in 3 out of 20 double mutants
|
cellular
• MEFs expressing the oncogenic protein do not undergo proliferative senescence and proliferate continuously as immortal cells
|
respiratory system
• a large spectrum of multifocal lesions are seen in the lung including; small patches of bronchiolo-alveolar hyperplasias to large bronchiolo-alveolar adenomas that compress adjacent lung structures and appear to derive from type II pneumocytes
|
• large bronchiolo-alveolar adenocarcinomas that compress adjacent lung structures and appear to derive from type II pneumocytes
|
• double mutants develop breathing difficulties after 7 - 8 months of age
|